4587.T Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 02:15):

PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics...

Stats
Today's Volume	856 100
Average Volume	845 080
Market Cap	210.22B
EPS	¥0 ( 2024-02-14 )
Next earnings date	( ¥10.93 ) 2024-05-08
Last Dividend	¥0 ( N/A )
Next Dividend	¥0 ( N/A )
P/E	69.17
ATR14	¥1.377 (0.08%)

Volume Correlation

Long: 0.28 (neutral)

Short: 0.44 (neutral)

Signal:(61.644) Neutral

PeptiDream Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

PeptiDream Inc. Correlation - Currency/Commodity

-0.38
( neutral )

-0.29
( neutral )

-0.41
( neutral )

-0.31
( neutral )

0.31
( neutral )

0.06
( neutral )

PeptiDream Inc. Financials

Annual	2023
Revenue:	¥28.71B
Gross Profit:	¥16.86B (58.73 %)
EPS:	¥23.41

FY	2023
Revenue:	¥28.71B
Gross Profit:	¥16.86B (58.73 %)
EPS:	¥23.41

FY	2022
Revenue:	¥26.85B
Gross Profit:	¥18.11B (67.46 %)
EPS:	¥58.19

FY	2021
Revenue:	¥9.37B
Gross Profit:	¥7.01B (74.82 %)
EPS:	¥28.70

Financial Reports:

No articles found.

PeptiDream Inc.

PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics. The company develops its products based on its Peptide Discovery Platform System, a drug finding platform for the development of peptides. It has a collaborative research and exclusive license agreement with Takeda Pharmaceutical Company Limited to develop peptide drug conjugates for neuromuscular diseases. The company was incorporated in 2006 and is headquartered in Kawasaki, Japan.